Charles Schwab’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $28K | Sell |
|
|||||
|
2024
Q4 | $83.9K | Hold |
|
|||||
|
2024
Q3 | $179K | Hold |
|
|||||
|
2024
Q2 | $147K | Buy |
|
|||||
|
2024
Q1 | $41.6K | Hold |
|
|||||
|
2023
Q4 | $28.9K | Hold |
|
|||||
|
2023
Q3 | $33.4K | Hold |
|
|||||
|
2023
Q2 | $25.1K | Hold |
|
|||||
|
2023
Q1 | $36.6K | Hold |
|
|||||
|
2022
Q4 | $19.7K | Hold |
|
|||||
|
2022
Q3 | $29K | Hold |
|
|||||
|
2022
Q2 | $23K | Hold |
|
|||||
|
2022
Q1 | $29K | Hold |
|
|||||
|
2021
Q4 | $37K | Hold |
|
|||||
|
2021
Q3 | $68K | Hold |
|
|||||
|
2021
Q2 | $56K | Sell |
|
|||||
|
2021
Q1 | $169K | Sell |
|
|||||
|
2020
Q4 | $192K | Hold |
|
|||||
|
2020
Q3 | $229K | Sell |
|
|||||
|
2020
Q2 | $285K | Buy |
|
|||||
|
2020
Q1 | $182K | Hold |
|
|||||
|
2019
Q4 | $265K | Hold |
|
|||||
|
2019
Q3 | $340K | Buy |
|
|||||
|
2019
Q2 | $312K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $102K | Hold |
|
|||||
|
2017
Q4 | $72K | Hold |
|
|||||
|
2017
Q3 | $46K | Hold |
|
|||||
|
2017
Q2 | $53K | Sell |
|
|||||
|
2017
Q1 | $351K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $89K | Hold |
|
|||||
|
2014
Q4 | $92K | Hold |
|
|||||
|
2014
Q3 | $133K | Hold |
|
|||||
|
2014
Q2 | $365K | Buy |
|